Nifty

:

25050.55

Sensex

:

81857.84

69.90 (0.28%)
213.45 (0.26%)

Login

Nifty
Sensex

:
:

25050.55
81857.84

69.90 (0.28%)
213.45 (0.26%)

Aarti Pharmalabs Ltd.

Pharmaceuticals & Drugs

Rating :

60/99

BSE: 543748 | NSE: AARTIPHARM

Watchlist

NSE BSE

840.75

20-Aug-2025

Open
High
Low
Previous Close

855
855
831
852.65

Volume
Traded Value (lacs)
52 Week High
52 Week Low

314786
264181896.85
971
557.05

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

7,620.21
28.60
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

8,007.91
0.59%
3.73

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
15.58

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
13.47

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
21.06

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
-
-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
-

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 23.93 30.06 36.13 40.09
P/E Ratio 35.13 27.97 23.27 20.97
Revenue 1816 2115 2546 2956
EBITDA 386 464 549 632
Net Income 217 272 328 363
ROA 9 9.9
P/B Ratio 4.70 3.83
ROE 13.08 14.54 14.3 13.9
FCFF 47 -88
FCFF Yield 0.56 -1.06
Net Debt 191 357
BVPS 178.92 219.55

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 375.31 393.49 -4.62% 529.62 414.82 27.67% 470.95 373.03 26.25% 377.29 356.14 5.94%
Expenses 280.18 309.83 -9.57% 386.50 307.47 25.70% 355.96 284.76 25.00% 292.52 282.34 3.61%
EBITDA 95.13 83.65 13.72% 143.13 107.34 33.34% 114.99 88.28 30.26% 84.77 73.80 14.86%
EBIDTM 25.35% 21.26% 27.02% 25.88% 24.42% 23.66% 22.47% 20.72%
Other Income 1.60 2.11 -24.17% -2.50 5.69 - 11.94 0.46 2,495.65% 2.95 0.00 0
Interest 6.80 4.25 60.00% 6.29 4.42 42.31% 9.70 4.36 122.48% 5.39 3.82 41.10%
Depreciation 22.76 18.29 24.44% 20.83 17.32 20.27% 21.04 16.94 24.20% 18.89 16.32 15.75%
PBT 67.17 63.23 6.23% 113.50 91.28 24.34% 96.18 67.44 42.62% 63.43 53.67 18.19%
Tax 15.95 16.08 -0.81% 24.66 28.26 -12.74% 22.66 19.25 17.71% 15.60 11.86 31.53%
PAT 51.22 47.14 8.66% 88.85 63.02 40.99% 73.52 48.19 52.56% 47.84 41.81 14.42%
PATM 13.65% 11.98% 16.78% 15.19% 15.61% 12.92% 12.68% 11.74%
EPS 5.65 5.20 8.65% 9.81 6.96 40.95% 8.12 5.32 52.63% 5.28 4.61 14.53%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 386.19 555.49 -30.48% 563.78 505.77 11.47% 537.78 448.69 19.86% 458.03 439.80 4.15%
Expenses 290.95 459.03 -36.62% 418.15 388.25 7.70% 409.17 353.01 15.91% 364.35 351.81 3.56%
EBITDA 95.24 96.46 -1.26% 145.63 117.51 23.93% 128.61 95.68 34.42% 93.67 87.99 6.46%
EBIDTM 24.66% 17.36% 25.83% 23.23% 23.91% 21.32% 20.45% 20.01%
Other Income 1.60 2.22 -27.93% -1.61 2.03 - 5.03 1.39 261.87% 4.48 0.99 352.53%
Interest 6.80 4.83 40.79% 6.58 4.68 40.60% 9.97 4.48 122.54% 5.51 3.89 41.65%
Depreciation 22.79 20.17 12.99% 22.82 19.12 19.35% 23.04 18.77 22.75% 20.88 18.14 15.10%
PBT 67.25 73.68 -8.73% 114.62 95.75 19.71% 100.63 73.82 36.32% 71.77 66.95 7.20%
Tax 15.95 18.22 -12.46% 26.28 30.50 -13.84% 26.64 21.05 26.56% 17.14 15.14 13.21%
PAT 51.30 55.45 -7.48% 88.34 65.25 35.39% 73.99 52.76 40.24% 54.62 51.80 5.44%
PATM 13.28% 9.98% 15.67% 12.90% 13.76% 11.76% 11.93% 11.78%
EPS 5.46 6.12 -10.78% 9.75 7.20 35.42% 8.16 5.82 40.21% 6.03 5.72 5.42%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22
Net Sales 1,753.17 1,502.13 1,511.25 941.02 Net Sales Growth 14.03% -0.60% 60.60% Cost Of Goods Sold 835.85 751.97 817.93 451.66 Gross Profit 917.32 750.16 693.32 489.36 GP Margin 52.32% 49.94% 45.88% 52.00% Total Expenditure 1,315.16 1,155.97 1,202.91 761.24 Power & Fuel Cost - 82.92 74.22 69.73 % Of Sales - 5.52% 4.91% 7.41% Employee Cost - 120.15 113.92 79.98 % Of Sales - 8.00% 7.54% 8.50% Manufacturing Exp. - 99.70 96.20 132.62 % Of Sales - 6.64% 6.37% 14.09% General & Admin Exp. - 28.39 29.30 6.98 % Of Sales - 1.89% 1.94% 0.74% Selling & Distn. Exp. - 49.19 48.54 20.25 % Of Sales - 3.27% 3.21% 2.15% Miscellaneous Exp. - 23.65 22.80 0.01 % Of Sales - 1.57% 1.51% 0.00% EBITDA 438.02 346.16 308.34 179.78 EBITDA Margin 24.98% 23.04% 20.40% 19.10% Other Income 13.99 11.01 1.28 2.51 Interest 28.18 16.63 20.49 11.34 Depreciation 83.52 66.01 55.77 37.23 PBT 340.28 274.52 233.36 133.73 Tax 78.87 73.87 61.63 27.00 Tax Rate 23.18% 26.91% 26.41% 20.19% PAT 261.43 200.65 171.73 106.73 PAT before Minority Interest 261.43 200.65 171.73 106.73 Minority Interest 0.00 0.00 0.00 0.00 PAT Margin 14.91% 13.36% 11.36% 11.34% PAT Growth 30.61% 16.84% 60.90% EPS 28.86 22.15 18.95 11.78

Description TTM Mar 24 Mar 23 Mar 22
Net Sales 1,945.78 1,852.61 1,945.23 1,199.94 Net Sales Growth -0.20% -4.76% 62.11% Cost Of Goods Sold 959.05 1,020.71 1,169.76 637.67 Gross Profit 986.73 831.89 775.48 562.27 GP Margin 50.71% 44.90% 39.87% 46.86% Total Expenditure 1,482.62 1,466.56 1,603.18 994.67 Power & Fuel Cost - 84.03 75.10 90.00 % Of Sales - 4.54% 3.86% 7.50% Employee Cost - 128.03 121.32 85.20 % Of Sales - 6.91% 6.24% 7.10% Manufacturing Exp. - 107.30 98.78 145.95 % Of Sales - 5.79% 5.08% 12.16% General & Admin Exp. - 30.08 30.20 8.13 % Of Sales - 1.62% 1.55% 0.68% Selling & Distn. Exp. - 68.88 74.83 27.38 % Of Sales - 3.72% 3.85% 2.28% Miscellaneous Exp. - 27.53 33.20 0.34 % Of Sales - 1.49% 1.71% 0.03% EBITDA 463.15 386.05 342.05 205.27 EBITDA Margin 23.80% 20.84% 17.58% 17.11% Other Income 9.50 4.89 2.32 4.19 Interest 28.86 17.21 21.05 11.96 Depreciation 89.53 73.24 62.54 42.12 PBT 354.27 300.49 260.77 155.38 Tax 86.01 83.59 67.28 33.13 Tax Rate 24.28% 27.82% 25.80% 21.32% PAT 268.25 216.90 193.49 122.25 PAT before Minority Interest 268.25 216.90 193.49 122.25 Minority Interest 0.00 0.00 0.00 0.00 PAT Margin 13.79% 11.71% 9.95% 10.19% PAT Growth 19.08% 12.10% 58.27% EPS 29.61 23.94 21.36 13.49

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22
Shareholder's Funds 1,621.46 1,438.58 1,284.28 Share Capital 45.31 45.31 0.25 Total Reserves 1,575.92 1,393.27 1,238.71 Non-Current Liabilities 119.87 74.04 60.88 Secured Loans 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 Long Term Provisions 5.28 4.66 0.00 Current Liabilities 555.58 463.75 481.67 Trade Payables 254.79 212.50 131.61 Other Current Liabilities 43.76 36.20 8.98 Short Term Borrowings 250.80 206.71 324.62 Short Term Provisions 6.24 8.33 16.46 Total Liabilities 2,296.91 1,976.37 1,826.83 Net Block 953.33 848.40 701.12 Gross Block 1,472.15 1,303.76 1,100.71 Accumulated Depreciation 518.82 455.37 399.59 Non Current Assets 1,162.85 1,010.15 936.56 Capital Work in Progress 136.92 101.90 187.37 Non Current Investment 43.83 42.67 39.87 Long Term Loans & Adv. 28.77 17.18 8.21 Other Non Current Assets 0.00 0.00 0.00 Current Assets 1,134.06 966.22 890.27 Current Investments 17.83 12.81 0.00 Inventories 582.15 537.68 444.38 Sundry Debtors 448.82 371.67 304.22 Cash & Bank 4.43 0.37 56.50 Other Current Assets 80.83 7.18 11.53 Short Term Loans & Adv. 66.86 36.51 73.65 Net Current Assets 578.48 502.47 408.60 Total Assets 2,296.91 1,976.37 1,826.83

Description Mar 24 Mar 23 Mar 22
Shareholder's Funds 1,757.04 1,558.49 1,386.48 Share Capital 45.31 45.31 0.25 Total Reserves 1,711.50 1,513.17 1,340.91 Non-Current Liabilities 130.68 84.91 72.76 Secured Loans 0.04 0.18 0.55 Unsecured Loans 0.00 0.00 0.00 Long Term Provisions 6.06 5.36 0.00 Current Liabilities 694.39 600.62 580.67 Trade Payables 378.32 339.50 214.59 Other Current Liabilities 45.84 38.33 11.89 Short Term Borrowings 263.92 213.78 337.73 Short Term Provisions 6.31 9.01 16.46 Total Liabilities 2,582.11 2,244.02 2,039.91 Net Block 1,033.33 925.84 782.09 Gross Block 1,609.29 1,431.25 1,225.00 Accumulated Depreciation 575.96 505.41 442.90 Non Current Assets 1,236.46 1,081.02 1,011.75 Capital Work in Progress 136.92 101.87 187.37 Non Current Investment 36.78 35.52 32.23 Long Term Loans & Adv. 29.44 17.78 10.07 Other Non Current Assets 0.00 0.00 0.00 Current Assets 1,345.64 1,163.01 1,028.15 Current Investments 70.39 50.99 0.00 Inventories 642.86 602.04 475.45 Sundry Debtors 519.34 450.10 376.66 Cash & Bank 24.07 12.19 83.27 Other Current Assets 88.98 7.70 10.74 Short Term Loans & Adv. 71.97 39.98 82.03 Net Current Assets 651.25 562.38 447.48 Total Assets 2,582.10 2,244.03 2,039.90

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22
Cash From Operating Activity 183.69 215.88 -64.84 PBT 274.52 233.36 133.73 Adjustment 80.71 76.87 46.08 Changes in Working Capital -124.55 -37.61 -229.65 Cash after chg. in Working capital 230.68 272.61 -49.84 Interest Paid 0.00 0.00 0.00 Tax Paid -46.99 -56.73 -15.00 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -184.40 -115.55 -133.54 Net Fixed Assets -203.41 -117.58 Net Investments -6.18 -15.61 Others 25.19 17.64 Cash from Financing Activity 4.40 -156.53 254.63 Net Cash Inflow / Outflow 3.70 -56.20 56.25 Opening Cash & Equivalents 0.30 56.50 0.25 Closing Cash & Equivalent 4.00 0.30 56.50

Description Mar 24 Mar 23 Mar 22
Cash From Operating Activity 216.35 250.12 -43.70 PBT 300.49 260.77 155.38 Adjustment 94.65 83.35 52.41 Changes in Working Capital -121.85 -31.63 -230.36 Cash after chg. in Working capital 273.29 312.50 -22.57 Interest Paid 0.00 0.00 0.00 Tax Paid -56.94 -62.38 -21.13 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -214.56 -157.80 -138.74 Net Fixed Assets -203.41 -117.58 Net Investments -6.18 -15.61 Others -4.97 -24.61 Cash from Financing Activity 9.72 -163.46 260.38 Net Cash Inflow / Outflow 11.51 -71.15 77.94 Opening Cash & Equivalents 12.12 83.27 5.33 Closing Cash & Equivalent 23.63 12.12 83.27

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22
Book Value (Rs.) 178.89 158.74 49558.52 ROA 9.39% 9.03% 11.68% ROE 13.11% 12.83% 17.23% ROCE 16.55% 15.60% 18.03% Fixed Asset Turnover 1.08 1.26 0.85 Receivable days 99.68 81.62 118.00 Inventory Days 136.05 118.59 172.36 Payable days 113.41 76.78 53.18 Cash Conversion Cycle 122.33 123.44 237.18 Total Debt/Equity 0.15 0.14 0.26 Interest Cover 17.50 12.39 12.79

Description Mar 24 Mar 23 Mar 22
Book Value (Rs.) 193.85 171.97 53646.60 ROA 8.99% 9.03% 11.98% ROE 13.08% 13.35% 18.23% ROCE 16.75% 16.11% 19.40% Fixed Asset Turnover 1.22 1.46 0.98 Receivable days 95.50 77.57 114.57 Inventory Days 122.63 101.09 144.62 Payable days 128.34 86.45 61.41 Cash Conversion Cycle 89.79 92.21 197.78 Total Debt/Equity 0.15 0.14 0.25 Interest Cover 18.46 13.39 13.99

Top Investors:

life insurance corporation of india

ntasain discovery master fund

nishant pradip shah

investor education and protection fund (iepf)

Annual Reports:

News Update:

Aarti Pharmalabs - Quarterly Results
12th Aug 2025, 19:24 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback